ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0261

Clinical Implications, Bacterial Profiles, and Patient Outcomes in Hospitalized Patients with Autoimmune Rheumatic Diseases

Angel Kevin Garza-Elizondo1, Ana Cecilia Bardan-Inchaustegui2, Pablo Gamez-Siller3, Diana Elsa Flores-Alvarado4, Jorge Esquivel-Valerio5, Jesus Cardenas-de la Garza2, Elsa Catalina Davila-Correa6, Alejandra Jacquelin Osuna-Corrales6, Karla Judith Duran-Villarreal6, Daniela Alejandra Salcedo-Soto7, Derek de Jesus Gauna-Leal6, Andrea Axelle Prado-Prado6, Debanhi Morales-Espronceda6, Nathalia Valdez-Benavides6, Nirvana Amairany González-Ontiveros6 and Dionicio Galarza-Delgado8, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, San Nicolás de los Garza, Mexico, 2Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 3Facultad de Medicina UANL, Monterrey, Nuevo León, Mexico, 4Hospital Universitario Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, MONTERREY, Mexico, 6Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Mexico, 7Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico, 8UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

Meeting: ACR Convergence 2024

Keywords: Health Care, health status, Infection, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Autoimmune rheumatic diseases (ARD) are chronic conditions that affect multiple organ systems. Patients with ARD tend to have a weak immune system due to disease activity or immunosuppressant treatments. These characteristics predispose to infections, thus a reason for frequent hospitalization. We aim to describe and indicate the clinical implications, bacterial profiles, and patient outcomes in hospitalized patients with ARD.

Methods: We conducted a descriptive, cross-sectional, and comparative study among patients hospitalized for infection with ARD diagnosis and referred to the rheumatology service in a university hospital. We excluded referred patients without infection and ARD diagnosis. Information collected was demographic data, hospitalization history, diagnosis of ARD, type of infection, isolated pathogens and antibiotic susceptibility profiles, and patient outcomes from March 2023 to April 2024. The Shapiro-Wilk test was used for the normality of quantitative variables, the Squared-Chi test to compare categoric variables, and the Mann-Whitney U to compare non-parametric continuous variables. A p-value < 0.05 was considered for statistically significant differences.

Results: A total of 55 hospitalized patients by infection were included, 51 (92.72%) were women and 4 (7.27%) were men. The mean age was 36 (SD 28). Forty-seven (85%) patients had medical discharge and eight (14.54%) died. Site of infections were 18 (32.72%) lung infections, 12 (21.81%) urinary tract infections, and 6 (10.9%) soft tissue infections. Immunosuppressant and glucocorticoid treatment is shown in Table 1. Escherichia coli was isolated in 10 cultures, Pseudomonas pp. in 6, and Staphylococcus aureus in 5. The rest of the isolated microorganisms are shown in Table 2

Conclusion: More than 85% of the patients were discharged and 14% died. There was a significant association between the immunosuppressant and glucocorticoid treatment and the clinical outcome of the patients. The primary site of infection was in the lungs followed by the urinary tract. More than 50% of the deaths were caused by a lung infection, but there was no association between the site of infection and the outcome of the patients. The most frequent microorganism was Escherichia coli and deaths were caused by Acinetobacter baumanii and Pseudomonas spp.

Supporting image 1

Table 1: Sociodemographic Factors, Anatomical Site of infection and treatment

Supporting image 2

Table 2: Isolated microorganisms


Disclosures: A. Garza-Elizondo: None; A. Bardan-Inchaustegui: None; P. Gamez-Siller: None; D. Flores-Alvarado: None; J. Esquivel-Valerio: None; J. Cardenas-de la Garza: None; E. Davila-Correa: None; A. Osuna-Corrales: None; K. Duran-Villarreal: None; D. Salcedo-Soto: None; D. Gauna-Leal: None; A. Prado-Prado: None; D. Morales-Espronceda: None; N. Valdez-Benavides: None; N. González-Ontiveros: None; D. Galarza-Delgado: None.

To cite this abstract in AMA style:

Garza-Elizondo A, Bardan-Inchaustegui A, Gamez-Siller P, Flores-Alvarado D, Esquivel-Valerio J, Cardenas-de la Garza J, Davila-Correa E, Osuna-Corrales A, Duran-Villarreal K, Salcedo-Soto D, Gauna-Leal D, Prado-Prado A, Morales-Espronceda D, Valdez-Benavides N, González-Ontiveros N, Galarza-Delgado D. Clinical Implications, Bacterial Profiles, and Patient Outcomes in Hospitalized Patients with Autoimmune Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-implications-bacterial-profiles-and-patient-outcomes-in-hospitalized-patients-with-autoimmune-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-implications-bacterial-profiles-and-patient-outcomes-in-hospitalized-patients-with-autoimmune-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology